| Trial ID: | L0235 |
| Source ID: | ChiCTR-IPR-17012342
|
| Associated Drug: |
Acipimox
|
| Title: |
Evaluation of Acipimox for the Treatment in patients with abnomal ALT non-alcoholic fatty liver disease: A Prospective, Randomized, Controlled clinical trial
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Acipimox treatment group:acipimox 0.25 tid po;lifestyle intervention group:Lifestyle Counselling;
|
| Outcome Measures: |
height;weight;waistline;hipline;blood pressure;blood routine examination;liver function;blood lipids;renal function;HbA1c;FBG;PPG;Fins;FFA;nan
|
| Sponsor/Collaborators: |
the Affiliated hospital of Southwest Medical University
|
| Gender: |
All
|
| Age: |
1470
|
| Phases: |
Post-market
|
| Enrollment: |
Acipimox treatment group:30;lifestyle intervention group:30;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Randomized parallel controlled trial
|
| Start Date: |
11/08/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
21 August 2017
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=18104
|
